Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) Profit Margin

Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s profit margin stands at -55.68% as of June 2026. That compares with -52.55% in the prior-year period — down 5.9% year over year. That is below the sector sector average of 21.34%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) reported -55.68% in profit margin versus -52.55% a year earlier — a 5.9% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) sits lower the its sector benchmark (21.34%) with a profit margin of -55.68%. That is roughly 360.9% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -55.68% for Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s profit margin evolved across reporting periods, while the comparison chart places DMAQU next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.